T2 Biosystems, Inc.
(NASDAQ : TTOO)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
BIIBBiogen, Inc.
-2.35%275.281.4%$809.31m
AMGNAmgen, Inc.
-0.48%217.171.3%$492.63m
CELGCelgene Corp.
-0.52%109.841.3%$454.34m
GILDGilead Sciences, Inc.
0.10%63.391.0%$379.42m
ILMNIllumina, Inc.
-0.23%297.553.5%$302.54m
VRTXVertex Pharmaceuticals, Inc.
-1.28%204.461.9%$295.96m
REGNRegeneron Pharmaceuticals, Inc.
-2.52%339.532.6%$257.96m
EXASEXACT Sciences Corp.
1.23%79.2124.0%$197.27m
ALXNAlexion Pharmaceuticals, Inc.
-1.59%105.432.0%$180.28m
SGENSeattle Genetics, Inc.
-0.37%111.806.1%$131.06m
BMRNBioMarin Pharmaceutical, Inc.
-0.65%75.654.3%$115.49m
SRPTSarepta Therapeutics, Inc.
-3.02%97.9514.6%$111.94m
AAgilent Technologies, Inc.
-0.42%76.841.6%$100.68m
MRTXMirati Therapeutics, Inc.
1.79%102.542.3%$88.17m
NBIXNeurocrine Biosciences, Inc.
-1.30%109.475.0%$84.56m

Company Profile

T2 Biosystems, Inc. engages in the development of proprietary technology platform. It offers the T2 Magnetic Resonance technology which enables rapid detection of pathogens, biomarkers and other abnormalities in a variety of unpurified patient sample types. It products include T2Bacteria Panel, T2Candida Panel, T2Dx Instrument, AND T2MR Technology. The company was founded by Michael J. Cima, Robert S. Langer Jr., Tyler Jacks, Lee Josephson, W. David Lee, and Ralph Weissleder on April 27, 2006 and is headquartered in Lexington, MA.